|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:DOCK5-FNTA (FusionGDB2 ID:HG80005TG2339) |
Fusion Gene Summary for DOCK5-FNTA |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: DOCK5-FNTA | Fusion gene ID: hg80005tg2339 | Hgene | Tgene | Gene symbol | DOCK5 | FNTA | Gene ID | 80005 | 2339 |
| Gene name | dedicator of cytokinesis 5 | farnesyltransferase, CAAX box, alpha | |
| Synonyms | - | FPTA|PGGT1A|PTAR2 | |
| Cytomap | ('DOCK5')('FNTA') 8p21.2 | 8p11.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | dedicator of cytokinesis protein 5 | protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaFTase-alphaGGTase-I-alphafarnesyl-protein transferase alpha-subunitprotein prenyltransferase alpha subunit repeat containing 2ras proteins prenyltransferase subunit alphatype | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9H7D0 | P49354 | |
| Ensembl transtripts involved in fusion gene | ENST00000276440, ENST00000410074, ENST00000481100, | ||
| Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 10 X 11 X 7=770 |
| # samples | 7 | 14 | |
| ** MAII score | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(14/770*10)=-2.4594316186373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: DOCK5 [Title/Abstract] AND FNTA [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | DOCK5(25101273)-FNTA(42919244), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | DOCK5-FNTA seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DOCK5-FNTA seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DOCK5-FNTA seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. DOCK5-FNTA seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | FNTA | GO:0018343 | protein farnesylation | 16893176|19228685 |
| Tgene | FNTA | GO:0018344 | protein geranylgeranylation | 16893176 |
| Tgene | FNTA | GO:0090044 | positive regulation of tubulin deacetylation | 19228685 |
| Tgene | FNTA | GO:0090045 | positive regulation of deacetylase activity | 19228685 |
| Fusion gene breakpoints across DOCK5 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across FNTA (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | TCGA-CG-5734-11A | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
Top |
Fusion Gene ORF analysis for DOCK5-FNTA |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000276440 | ENST00000524546 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-3UTR | ENST00000410074 | ENST00000524546 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-3UTR | ENST00000481100 | ENST00000524546 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-5UTR | ENST00000276440 | ENST00000529687 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-5UTR | ENST00000410074 | ENST00000529687 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-5UTR | ENST00000481100 | ENST00000529687 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-intron | ENST00000276440 | ENST00000342116 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-intron | ENST00000410074 | ENST00000342116 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| 5CDS-intron | ENST00000481100 | ENST00000342116 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| In-frame | ENST00000276440 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| In-frame | ENST00000410074 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| In-frame | ENST00000481100 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000276440 | DOCK5 | chr8 | 25101273 | + | ENST00000302279 | FNTA | chr8 | 42919244 | + | 1531 | 171 | 44 | 1024 | 326 |
| ENST00000410074 | DOCK5 | chr8 | 25101273 | + | ENST00000302279 | FNTA | chr8 | 42919244 | + | 1673 | 313 | 186 | 1166 | 326 |
| ENST00000481100 | DOCK5 | chr8 | 25101273 | + | ENST00000302279 | FNTA | chr8 | 42919244 | + | 1624 | 264 | 137 | 1117 | 326 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000276440 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + | 0.000412005 | 0.99958795 |
| ENST00000410074 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + | 0.000483886 | 0.9995161 |
| ENST00000481100 | ENST00000302279 | DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919244 | + | 0.000482329 | 0.9995177 |
Top |
Fusion Genomic Features for DOCK5-FNTA |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919243 | + | 4.53E-08 | 1 |
| DOCK5 | chr8 | 25101273 | + | FNTA | chr8 | 42919243 | + | 4.53E-08 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for DOCK5-FNTA |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:25101273/chr8:42919244) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| DOCK5 | FNTA |
| FUNCTION: Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP (By similarity). Along with DOCK1, mediates CRK/CRKL regulation of epithelial and endothelial cell spreading and migration on type IV collagen (PubMed:19004829). {ECO:0000250|UniProtKB:B2RY04, ECO:0000269|PubMed:19004829}. | FUNCTION: Essential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. Contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl diphosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. May positively regulate neuromuscular junction development downstream of MUSK via its function in RAC1 prenylation and activation. {ECO:0000269|PubMed:12036349, ECO:0000269|PubMed:12825937, ECO:0000269|PubMed:16893176, ECO:0000269|PubMed:19246009, ECO:0000269|PubMed:8419339, ECO:0000269|PubMed:8494894}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 22_31 | 0 | 313.0 | Compositional bias | Note=Pro-rich | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 112_146 | 95 | 380.0 | Repeat | Note=PFTA 1 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 147_180 | 95 | 380.0 | Repeat | Note=PFTA 2 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 181_215 | 95 | 380.0 | Repeat | Note=PFTA 3 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 216_249 | 95 | 380.0 | Repeat | Note=PFTA 4 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 255_289 | 95 | 380.0 | Repeat | Note=PFTA 5 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 112_146 | 0 | 313.0 | Repeat | Note=PFTA 1 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 147_180 | 0 | 313.0 | Repeat | Note=PFTA 2 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 181_215 | 0 | 313.0 | Repeat | Note=PFTA 3 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 216_249 | 0 | 313.0 | Repeat | Note=PFTA 4 | |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000342116 | 0 | 7 | 255_289 | 0 | 313.0 | Repeat | Note=PFTA 5 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000276440 | + | 2 | 52 | 1782_1855 | 42 | 1871.0 | Compositional bias | Note=Pro-rich |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000481100 | + | 2 | 11 | 1782_1855 | 42 | 351.0 | Compositional bias | Note=Pro-rich |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000276440 | + | 2 | 52 | 1231_1642 | 42 | 1871.0 | Domain | DOCKER |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000276440 | + | 2 | 52 | 443_627 | 42 | 1871.0 | Domain | C2 DOCK-type |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000276440 | + | 2 | 52 | 8_69 | 42 | 1871.0 | Domain | SH3 |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000481100 | + | 2 | 11 | 1231_1642 | 42 | 351.0 | Domain | DOCKER |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000481100 | + | 2 | 11 | 443_627 | 42 | 351.0 | Domain | C2 DOCK-type |
| Hgene | DOCK5 | chr8:25101273 | chr8:42919244 | ENST00000481100 | + | 2 | 11 | 8_69 | 42 | 351.0 | Domain | SH3 |
| Tgene | FNTA | chr8:25101273 | chr8:42919244 | ENST00000302279 | 1 | 9 | 22_31 | 95 | 380.0 | Compositional bias | Note=Pro-rich |
Top |
Fusion Gene Sequence for DOCK5-FNTA |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >23809_23809_1_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000276440_FNTA_chr8_42919244_ENST00000302279_length(transcript)=1531nt_BP=171nt TGTAGCAGCCTTAGTCGCCGCCGCCGCGGGGCGAGGTCGCCGCCATGGCCCGCTGGATCCCGACCAAGAGGCAGAAGTACGGGGTTGCGA TCTATAACTACAATGCTTCTCAAGATGTGGAGCTCTCCTTGCAGATCGGTGACACAGTTCACATCCTGGAGATGTACGAGGTTAGAGATG TTTATGATTACTTCCGAGCTGTCCTGCAGCGTGATGAAAGAAGTGAACGAGCTTTTAAGCTAACCCGGGATGCTATTGAGTTAAATGCAG CCAATTATACAGTGTGGCATTTCCGGAGAGTTCTTTTGAAGTCACTTCAGAAGGATCTACATGAGGAAATGAACTACATCACTGCAATAA TTGAGGAGCAGCCCAAAAACTATCAAGTTTGGCATCATAGGCGAGTATTAGTGGAATGGCTAAGAGATCCATCTCAGGAGCTTGAATTTA TTGCTGATATTCTTAATCAGGATGCAAAGAATTATCATGCCTGGCAGCATCGACAATGGGTTATTCAGGAATTTAAACTTTGGGATAATG AGCTGCAGTATGTGGACCAACTTCTGAAAGAGGATGTGAGAAATAACTCTGTCTGGAACCAAAGATACTTCGTTATTTCTAACACCACTG GCTACAATGATCGTGCTGTATTGGAGAGAGAAGTCCAATACACTCTGGAAATGATTAAACTAGTACCACATAATGAAAGTGCATGGAACT ATTTGAAAGGGATTTTGCAGGATCGTGGTCTTTCCAAATATCCTAATCTGTTAAATCAATTACTTGATTTACAACCAAGTCATAGTTCCC CCTACCTAATTGCCTTTCTTGTGGATATCTATGAAGACATGCTAGAAAATCAGTGTGACAATAAGGAAGACATTCTTAATAAAGCATTAG AGTTATGTGAAATCCTAGCTAAAGAAAAGGACACTATAAGAAAGGAATATTGGAGATACATTGGAAGATCCCTTCAAAGCAAACACAGCA CAGAAAATGACTCACCAACAAATGTACAGCAATAACACCATCCAGAAGAACTTGATGGAATGCTTTTATTTTTTATTAAGGGACCCTGCA GGAGTTTCACACGAGAGTGGTCCTTCCCTTTGCCTGTGGTGTAAAAGTGCATCACACAGGTATTGCTTTTTAACAAGAACTGATGCTCCT TGGGTGCTGCTGCTACTCAGACTAGCTCTAAGTAATGTGATTCTTCTAAAGCAAAGTCATTGGATGGGAGGAGGAAGAAAAAGTCCCATA AAGGAACTTTTGTAGTCTTATCAACATATAATCTAATCCCTTAGCATCAGCTCCTCCCTCAGTGGTACATGCGTCAAGATTTGTAGCAGT AATAACTGCAGGTCACTTGTATGTAATGGATGTGAGGTAGCCGAAGTTTGGTTCAGTAAGCAGGGAATACAGTCGTTCCATCAGAGCTGG TCTGCACACTCACATTATCTTGCTATCACTGTAACCAACTAATGCCAAAAGAACGGTTTTGTAATAAAATTATAGCTGTATCTAAAAACA >23809_23809_1_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000276440_FNTA_chr8_42919244_ENST00000302279_length(amino acids)=326AA_BP=42 MARWIPTKRQKYGVAIYNYNASQDVELSLQIGDTVHILEMYEVRDVYDYFRAVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLKS LQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFKLWDNELQYVDQLLKEDVRN NSVWNQRYFVISNTTGYNDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSKYPNLLNQLLDLQPSHSSPYLIAFLVDIYEDML -------------------------------------------------------------- >23809_23809_2_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000410074_FNTA_chr8_42919244_ENST00000302279_length(transcript)=1673nt_BP=313nt GCGGGCGGCGCGGGCACGGGCACGGGCGCGGGCGGCGCGGCGAGGAGGCGGCCCGCGGAGTCCAGCGAAGTTTGGCGGAACATGGCGGAA GCGTCTGGGGCACGCAGGAGCGCGGGGCGGCGGCGGCCGGAGCCCGAGGAGCTGTAGCAGCCTTAGTCGCCGCCGCCGCGGGGCGAGGTC GCCGCCATGGCCCGCTGGATCCCGACCAAGAGGCAGAAGTACGGGGTTGCGATCTATAACTACAATGCTTCTCAAGATGTGGAGCTCTCC TTGCAGATCGGTGACACAGTTCACATCCTGGAGATGTACGAGGTTAGAGATGTTTATGATTACTTCCGAGCTGTCCTGCAGCGTGATGAA AGAAGTGAACGAGCTTTTAAGCTAACCCGGGATGCTATTGAGTTAAATGCAGCCAATTATACAGTGTGGCATTTCCGGAGAGTTCTTTTG AAGTCACTTCAGAAGGATCTACATGAGGAAATGAACTACATCACTGCAATAATTGAGGAGCAGCCCAAAAACTATCAAGTTTGGCATCAT AGGCGAGTATTAGTGGAATGGCTAAGAGATCCATCTCAGGAGCTTGAATTTATTGCTGATATTCTTAATCAGGATGCAAAGAATTATCAT GCCTGGCAGCATCGACAATGGGTTATTCAGGAATTTAAACTTTGGGATAATGAGCTGCAGTATGTGGACCAACTTCTGAAAGAGGATGTG AGAAATAACTCTGTCTGGAACCAAAGATACTTCGTTATTTCTAACACCACTGGCTACAATGATCGTGCTGTATTGGAGAGAGAAGTCCAA TACACTCTGGAAATGATTAAACTAGTACCACATAATGAAAGTGCATGGAACTATTTGAAAGGGATTTTGCAGGATCGTGGTCTTTCCAAA TATCCTAATCTGTTAAATCAATTACTTGATTTACAACCAAGTCATAGTTCCCCCTACCTAATTGCCTTTCTTGTGGATATCTATGAAGAC ATGCTAGAAAATCAGTGTGACAATAAGGAAGACATTCTTAATAAAGCATTAGAGTTATGTGAAATCCTAGCTAAAGAAAAGGACACTATA AGAAAGGAATATTGGAGATACATTGGAAGATCCCTTCAAAGCAAACACAGCACAGAAAATGACTCACCAACAAATGTACAGCAATAACAC CATCCAGAAGAACTTGATGGAATGCTTTTATTTTTTATTAAGGGACCCTGCAGGAGTTTCACACGAGAGTGGTCCTTCCCTTTGCCTGTG GTGTAAAAGTGCATCACACAGGTATTGCTTTTTAACAAGAACTGATGCTCCTTGGGTGCTGCTGCTACTCAGACTAGCTCTAAGTAATGT GATTCTTCTAAAGCAAAGTCATTGGATGGGAGGAGGAAGAAAAAGTCCCATAAAGGAACTTTTGTAGTCTTATCAACATATAATCTAATC CCTTAGCATCAGCTCCTCCCTCAGTGGTACATGCGTCAAGATTTGTAGCAGTAATAACTGCAGGTCACTTGTATGTAATGGATGTGAGGT AGCCGAAGTTTGGTTCAGTAAGCAGGGAATACAGTCGTTCCATCAGAGCTGGTCTGCACACTCACATTATCTTGCTATCACTGTAACCAA >23809_23809_2_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000410074_FNTA_chr8_42919244_ENST00000302279_length(amino acids)=326AA_BP=42 MARWIPTKRQKYGVAIYNYNASQDVELSLQIGDTVHILEMYEVRDVYDYFRAVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLKS LQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFKLWDNELQYVDQLLKEDVRN NSVWNQRYFVISNTTGYNDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSKYPNLLNQLLDLQPSHSSPYLIAFLVDIYEDML -------------------------------------------------------------- >23809_23809_3_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000481100_FNTA_chr8_42919244_ENST00000302279_length(transcript)=1624nt_BP=264nt GGCCCGCGGAGTCCAGCGAAGTTTGGCGGAACATGGCGGAAGCGTCTGGGGCACGCAGGAGCGCGGGGCGGCGGCGGCCGGAGCCCGAGG AGCTGTAGCAGCCTTAGTCGCCGCCGCCGCGGGGCGAGGTCGCCGCCATGGCCCGCTGGATCCCGACCAAGAGGCAGAAGTACGGGGTTG CGATCTATAACTACAATGCTTCTCAAGATGTGGAGCTCTCCTTGCAGATCGGTGACACAGTTCACATCCTGGAGATGTACGAGGTTAGAG ATGTTTATGATTACTTCCGAGCTGTCCTGCAGCGTGATGAAAGAAGTGAACGAGCTTTTAAGCTAACCCGGGATGCTATTGAGTTAAATG CAGCCAATTATACAGTGTGGCATTTCCGGAGAGTTCTTTTGAAGTCACTTCAGAAGGATCTACATGAGGAAATGAACTACATCACTGCAA TAATTGAGGAGCAGCCCAAAAACTATCAAGTTTGGCATCATAGGCGAGTATTAGTGGAATGGCTAAGAGATCCATCTCAGGAGCTTGAAT TTATTGCTGATATTCTTAATCAGGATGCAAAGAATTATCATGCCTGGCAGCATCGACAATGGGTTATTCAGGAATTTAAACTTTGGGATA ATGAGCTGCAGTATGTGGACCAACTTCTGAAAGAGGATGTGAGAAATAACTCTGTCTGGAACCAAAGATACTTCGTTATTTCTAACACCA CTGGCTACAATGATCGTGCTGTATTGGAGAGAGAAGTCCAATACACTCTGGAAATGATTAAACTAGTACCACATAATGAAAGTGCATGGA ACTATTTGAAAGGGATTTTGCAGGATCGTGGTCTTTCCAAATATCCTAATCTGTTAAATCAATTACTTGATTTACAACCAAGTCATAGTT CCCCCTACCTAATTGCCTTTCTTGTGGATATCTATGAAGACATGCTAGAAAATCAGTGTGACAATAAGGAAGACATTCTTAATAAAGCAT TAGAGTTATGTGAAATCCTAGCTAAAGAAAAGGACACTATAAGAAAGGAATATTGGAGATACATTGGAAGATCCCTTCAAAGCAAACACA GCACAGAAAATGACTCACCAACAAATGTACAGCAATAACACCATCCAGAAGAACTTGATGGAATGCTTTTATTTTTTATTAAGGGACCCT GCAGGAGTTTCACACGAGAGTGGTCCTTCCCTTTGCCTGTGGTGTAAAAGTGCATCACACAGGTATTGCTTTTTAACAAGAACTGATGCT CCTTGGGTGCTGCTGCTACTCAGACTAGCTCTAAGTAATGTGATTCTTCTAAAGCAAAGTCATTGGATGGGAGGAGGAAGAAAAAGTCCC ATAAAGGAACTTTTGTAGTCTTATCAACATATAATCTAATCCCTTAGCATCAGCTCCTCCCTCAGTGGTACATGCGTCAAGATTTGTAGC AGTAATAACTGCAGGTCACTTGTATGTAATGGATGTGAGGTAGCCGAAGTTTGGTTCAGTAAGCAGGGAATACAGTCGTTCCATCAGAGC TGGTCTGCACACTCACATTATCTTGCTATCACTGTAACCAACTAATGCCAAAAGAACGGTTTTGTAATAAAATTATAGCTGTATCTAAAA >23809_23809_3_DOCK5-FNTA_DOCK5_chr8_25101273_ENST00000481100_FNTA_chr8_42919244_ENST00000302279_length(amino acids)=326AA_BP=42 MARWIPTKRQKYGVAIYNYNASQDVELSLQIGDTVHILEMYEVRDVYDYFRAVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLKS LQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFKLWDNELQYVDQLLKEDVRN NSVWNQRYFVISNTTGYNDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSKYPNLLNQLLDLQPSHSSPYLIAFLVDIYEDML -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for DOCK5-FNTA |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DOCK5-FNTA |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | FNTA | P49354 | DB06448 | Lonafarnib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for DOCK5-FNTA |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies